News
The one-shot vaccine, developed by Panacea Biotec and branded as DengiAll, is being tested through a multi-centre, ...
3hon MSN
Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...
Health authorities in HCM City have issued an urgent alert after six people died from dengue fever, amid a spike in ...
1d
India Today on MSNHealth watch | What to do if you get dengueWith dengue on the rise this monsoon, doctors advise rest, hydration and medical care. Avoid panic, self-treatment and online ...
7h
TheHealthSite on MSNWHO Issues First-Ever Clinical Guidelines For Dengue, Zika, Chikungunya, And Yellow Fever Amid Sudden Spike In CasesWHO has issued guidelines to tackle the arbovirus diseases, which continue to be a major threat to life. Read on to know it ...
The phase III clinical trial enrolment for India's first one-shot dengue vaccine, DengiAll, developed by Panacea Biotec, is set to complete with 10,500 participants across 20 centers. This trial aims ...
The Nation UAE on MSN4h
Call for emergency measures to curb dengue spreadIn light of the recent spell of monsoon rains, Punjab Health Ministers Khawaja Salman Rafique and Khawaja Imran Nazir have stressed the need for immediate and emergency measures to prevent the spread ...
The Agency is urging travellers to protect themselves from diseases while on holiday with some simple extra steps ...
India faces a surge in viral fevers, dengue, and typhoid during monsoons due to stagnant water, humidity, and poor sanitation ...
Punjab's Health Minister Dr. Balbir Singh leads a surprise inspection as part of an anti-dengue initiative. Mosquito larvae ...
The number of dengue and malaria cases in the city has gone down considerably, said a report prepared by the Kolkata ...
Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for completion by October.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results